Selective DYRK1A Inhibitor for the Treatment of Neurodegenerative Diseases: Alzheimer, Parkinson, Huntington, and Down Syndrome

Documenti analoghi

• Tricyclic Pyrimidines As Inhibitors of DYRK1A/DYRK1B As Potential Treatment for Down’s Syndrome or Alzheimer’s Disease
  di: Rosse, Gerard
  Pubblicazione: (2013)
• Modulation of Tropomyosin Receptor Kinase for the Treatment of Neurotrophin Diseases: Alzheimer’s, Huntington’s and Parkinson’s
  di: Kargbo, Robert B.
  Pubblicazione: (2019)
• Approaches for Prevention and Treatment of Neurodegenerative Diseases: ALS and Alzheimer’s
  di: Kargbo, Robert B.
  Pubblicazione: (2019)
• β-Secretase Inhibitors for the Treatment of Alzheimer’s Disease and Down’s Syndrome
  di: Abdel-Magid, Ahmed F.
  Pubblicazione: (2013)
• Neurodegenerative disorders: Parkinson's disease and Huntington's disease
  di: Hague, S, et al.
  Pubblicazione: (2005)